IMI 2021 Reports and Digest - Reflections on the Implications for Clinical Practice

Area of Science:

• Ophthalmology and Vision Science
• Public Health
• Medical Research

Background:

• Increasing prevalence of myopia globally necessitates advanced research and management strategies.
• The International Myopia Institute (IMI) convenes experts to foster collaboration in myopia research and education.
• Growing concerns about vision impairment and blindness linked to myopia progression.

Purpose of the Study:

• To synthesize recent research on myopia, including pathologic myopia, risk factors, and progression.
• To update evidence-based consensus white papers on myopia control and management.
• To provide clear clinical guidance on myopia treatment initiation, cessation, and approach selection.

Main Methods:

• Consensus-building through collaborative reports from scientists, clinicians, and policymakers.
• Systematic review and synthesis of research published in the last 18 months.
• Development of evidence-based white papers and clinical guidance documents.

Main Results:

• Latest reports cover pathologic myopia, impact, risk factors, and prevention strategies.
• Updated white papers emphasize the importance of myopia control and environmental modifications.
• Comprehensive guidance is provided on treatment protocols, including timing and modality selection.

Conclusions:

• The IMI's work provides critical, evidence-based insights for managing myopia.
• Effective myopia control strategies are essential to reduce future vision impairment.
• Informed clinical decision-making is crucial for optimizing patient care and outcomes in myopia management.